Formoterol (Foradil®) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma

Pulmonary Pharmacology and Therapeutics

Volumn 16, Issue 5, 2003, Pages 299-306

  Mitchell, C ^a   Jenkins, C ^b   Scicchitano, R ^c   Rubinfeld, A ^d   Kottakis, J ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

Author keywords

Asthma; Bronchodilator; Foradil ; Formoterol; Inhaled corticosteroids

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; CREATININE; FORMOTEROL; FORMOTEROL FUMARATE; HYDROCORTISONE; SALBUTAMOL; CORTICOSTEROID; ETHANOLAMINE DERIVATIVE;

ADD ON THERAPY; ADRENAL SUPPRESSION; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEADACHE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEG CRAMP; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; AUSTRALIA; DRUG ADMINISTRATION; DRUG COMBINATION; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; AUSTRALIA; BECLOMETHASONE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; HUMANS; MALE; MIDDLE AGED;

EID: 0038498493     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1094-5539(03)00071-3     Document Type: Article

References (36)

1. National Heart, Lung, and Blood Institute. Global Initiative for Asthma: Pocket Guide for Asthma Management and Prevention. NHLBI/WHO NIH. 1998;. Publication No 96-3658B.
2. Greening A.P., Ind P.W., Northfield M., Shaw G. Added salmeterol versus higher-dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroids: Allen and Hanburys Limited UK Study Group. Lancet. 344:1994;219-224.
3. Pauwels R.A., Löfdahl C.G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) international study group. N Eng J Med. 337:1997;1405-1411.
4. Vermetten F.A., Boermans A.J., Luiten W.D., Mulder P.G., Vermue N.A. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids. J Asthma. 36:1999;97-106.
5. Murray J.J., Church N.L., Anderson W.H., Bernstein D.I., Wenzel S.E., Emmett A., Rickard K.A. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increase. Allergy Asthma Proc. 20:1999;173-180.
6. van Noord J.A., Schreurs A.J., Mol S.J., Mulder P.G. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax. 54:1999;207-212.
7. Condemi J.J., Goldstein S., Kelberg C., Yancey S., Emmett A., Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol. 82:1999;383-389.
8. Bouros D., Bachlitzanakis N., Kottakis J., Pfister P., Polychronopoulos V., Papadakis E., Constantopoulos S., Froundarakis M., Sichletidis L., Siafakas N. Formoterol and beclomethasone versus higher doses beclomethasone as maintenance therapy in adult asthma. Eur Respir J. 14:1999;627-632.
9. Kelsen S.G., Churh N.L., Gillman S.A., Lanier B.Q., Emmett A.H., Rickard K.A., Anderson W.H. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial. J Asthma. 36:1999;703-715.
10. van Noord J.A., Smeets J.J., Raaijmakers J.A., Bommer A.M., Marsen F.P. Salmeterol versus formoterol in patients with moderately severe asthma; onset and duration of action. Eur Respir J. 9:1996;1684-1688.
11. Wallin A., Sandstrom T., Rosenhall L., Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax. 48:1993;611-614.
12. Shrewsbury S., Pyke S., Britton M. Meta analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ. 320:2000;1368-1373.
13. Kips J.C., O'Connor B.J., Inman M.D., Svensson K., Pauwels R.A., O'Byrne P.M. A long-term study of the anti-inflammatory effects of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med. 161:2000;996-1001.
14. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., Runnerstrom E., Sandstrom T., Svensson K., Tatterfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma. The OPTIMA randomised trial. Am J Respir Crit Care Med. 164:2001;1392-1397.
15. Woolcock A., Lundback B., Ringdal N., Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 153:1996;1481-1488.
16. McIntyre H.D., Mitchell C., Bowler S., Armstrong J., Wooller J., Cowley D. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 h specimens. Thorax. 50:1995;1280-1284.
17. Altman D.G. Comparability of randomised groups. Statistician. 34:1985;125-136.
18. Senn S.J. Covariate imbalance and random allocation in clinical trials. Stat Med. 8:1989;467-475.
19. Senn S.J., Auclair P. The graphical presentation of clinical trials with particular reference to measurements over time. Stat Med. 9:1990;1287-1302.
20. van Elteren P.H. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst. 37:1960;351-361.
21. National asthma campaign management handbook, National asthma campaign, South Melbourne, 1996.
22. 2-agonists in asthma therapy. Chest. 113:1998;1095-1108.
23. 2-agonists and corticosteroids. Eur Respir J. 19:2002;182-191.
24. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 159:(9):1999;941-955.
25. Pedersen S., Fuglsang G. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J. 1:1988;433-435.
26. Löfdahl C.G., Mellstrand T., Svedmyr N. Glucocorticosteroids and asthma - studies of resistance and systemic effects of glucocorticosteroids. Eur J Respir Dis. 65:(Suppl 130):1989;69-79.
27. Barnes P.J. Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids. Respir Med. 95:(Suppl B):2001;S12-S16.
28. Bowler S. Inhaled steroids in asthma. Should the dose be reduced? Aus Fam Physic. 31:(8):2002;746-748.
29. ®) is effective and safe in the treatment of steroid-dependent asthma. Respir Med. 93:1999;876-884.
30. TM in patients with moderate-to-severe asthma. Respir Med. 96:(96):2002;851-861.
31. Kelly H.W. Establishing a therapeutic index for the inhaled corticosteroids: part 1. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids. J Allergy Clin Immunol. 102:1998;S36-S51.
32. Adams N., Bestall J.M., Jones P.W. Fluticasone versus beclomethasone or budesonide for chronic asthma. Cochrane Database Syst Rev. 1:2002;CD002310.
33. Remington T.L., Heaberlin A.M., DiGiovine B. Combined budesonide/formoterol turbuhaler treatment of asthma. Ann Pharmacother. 36:2002;1918-1928.
34. Markham A., Jarvis B. Inhaled salmeterol/fluticasone propionate combination. A review of its use in persistent asthma. Drugs. 60:2000;1207-1233.
35. Tattersfield A.E., Postma D.S., Barnes P.J., Svensson K., Bauer C.A., O'Byrne P.M., Löfdahl C.G., Pauwels R.A., Ullman A. Exacerbations of asthma. Am J Respir Crit Care Med. 160:1999;594-599.
36. Kaik G., Kottakis T., Anagnostopoulou O., Sichletidis L., Bachlatzanakis N., D'Amata M., Zucchi L., Cruz A.A., Pizzichini M., Vieira J.R., Beard M., Davis M.M., Overend T. Sequential therapy with formoterol (Foradil) plus budesonide (Miflonide) versus a fixed combination of salmeterol and fluticasone (Seretide) in asthma self-management. Eur Respir J. 20:(Suppl 38):2002;388S.